Latest News about PFE
Recent news which mentions PFE
IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderly
November 29, 2022
From MarketWatch
3 Reasons Pfizer Stock Will Crush the Broader Market in 2023
November 29, 2022
From Motley Fool
7 Stocks to Buy for the Upcoming Santa Claus Rally
November 28, 2022
From InvestorPlace
China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says Fauci
November 28, 2022
From MarketWatch
2 Biotech Stocks You Can Buy and Hold for the Next Decade
November 28, 2022
From Motley Fool
From Benzinga
From MarketWatch
Is Novavax Stock a Buy Now?
November 26, 2022
From Motley Fool
Better Dividend Stock: AbbVie or Viatris?
November 26, 2022
From Motley Fool
From Benzinga
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains
November 25, 2022
From Benzinga
As COVID cases rise, China locks down despite criticism
November 25, 2022
Tickers
PFE
Tags
PFE
From MarketWatch
Is Now the Time for Income Investors to Buy This Big Pharma Stock?
November 24, 2022
From Motley Fool
Novavax Stock: Buy, Sell, or Hold in 2023?
November 24, 2022
From Motley Fool
From Benzinga
PFE Stock Could Be the Booster Shot Your Portfolio Needs Now
November 23, 2022
From InvestorPlace
Jim Cramer Says China's Vaccines 'Don't Work' But Xi Won't Admit It
November 22, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 22, 2022
From Benzinga
Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
November 22, 2022
From MarketWatch
From Benzinga
China’s three-week COVID case tally tops 253,000 and daily average is rising, government says
November 22, 2022
From MarketWatch
A Look Into Healthcare Sector Value Stocks
November 21, 2022
From Benzinga
2 Reasons to Buy Pfizer and 1 Reason to Sell
November 20, 2022
From Motley Fool
3 Unstoppable Growth Stocks to Buy and Hold
November 19, 2022
From Motley Fool
Here's What Value Stocks Can Do for a Growth Investor
November 18, 2022
From Motley Fool
Pfizer Is Worst-Performing US Large-Cap Pharma Stock This Year, Its Investment Case Is Complex Yet Rewarding
November 18, 2022
Tickers
PFE
From Benzinga
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
November 18, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
November 18, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.